Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for general anesthesia in cardiac surgery
ChiCTR2200060907Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in cardiac disease (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Hemodynamic parameters and Incidence of intraoperative awareness. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
cardiac disease
Beyond the preview
Go deeper on ChiCTR2200060907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060907.